WEDNESDAY, Aug. 9, 2023 (HealthDay News) — New research shows hard-to-diagnose blood disorders called myelodysplastic syndromes/neoplasms (MDS) are often misdiagnosed and a second opinion may be needed. The difficulty of diagnosis and frequent misdiagnosis puts patients at increased risk for treatment mistakes and other potentially harmful consequences, according to researchersContinue Reading